share print

A patient

As a patient you are at the heart of everything we do

As specialists in women’s health and endocrinology, we strive to develop and market medicines to serve your unmet medical requirements. It has been our dream from the outset to provide patients with the best treatments possible and champion access to medicines across the world. We aim to provide you with the care and support you need.

To find out in more detail what we do, and how we can help you, please visit the HRA Pharma way page.

Further useful information for you as a patient can be found on the following HRA Pharma pages:
HRA Pharma clinical trials  
Our research & innovation model 
• Our pipeline : Women's health, endocrinology, cell therapy

We are here for you

Caring for patients is extremely important to us. We achieve this through close collaboration with healthcare professionals (pharmacist, GPs and specialists) and fostering open communication with patients.
If you have a particular question or would like information concerning one of our products, please contact us. 

Women’s health products*

*Please be aware that the availability of treatments, use and brand names may differ from country to country. We advise you to consult your doctor or pharmacist for further advice and to always read instructions carefully before using a product.

We put women at the center of our product development and health education efforts.


Emergency contraception  
Emergency contraception aims to prevent a pregnancy after unprotected sex or contraceptive failure. It should be taken as soon as possible after an unprotected sex.

Contraception  
Regular contraception is a planned use of various devices, drugs or surgical procedures to prevent and plan the timing of pregnancy.

Intimate health  
HRA Pharma intimate health products are designed to treat women who suffer from vaginitis, vaginal injury, and vaginal dryness.

Genital herpes  
Our product line also extends to the symptomatic treatment of genital herpes.

Uterine fibroids  
Uterine fibroids are solid tumours of the female genital tract in women of reproductive age.

About 20 percent to 40 percent* of women develop fibroids during their fertile years. Heavy menstrual bleeding (HMB), pelvic pressure and pain, and reproductive dysfunction are common symptoms** that impair women's health and quality of life. Heavy menstrual bleeding (HMB), pelvic pressure and pain, and reproductive dysfunction are common symptoms that impair women's health and quality of life.
*Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004;104:393–406.
**Stewart EA. Uterine fibroids. Lancet 2001;357:293–8. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002;17:1424-30.

About 20 percent to 40 percent* of women develop fibroids during their fertile years.
*Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004;104:393–406.



HRA Pharma endocrinology products*

*Please be aware that the availability of treatments, use and brand names may differ from country to country. We advise you to consult your doctor for further advice and to always read instructions carefully before using a product.

Our research and partnerships are far reaching, as we strive to continuously push the boundaries of treatments in endocrinology.


Adrenal cancer / Cushing's syndrome
If you suffer from advanced adrenal cortical carcinoma (ACC) or Cushing’s syndrome, we have treatments available to help you.

Anyone can get Cushing's syndrome, although it tends to affect adults aged 20-50 years. Women are three times more likely to develop the syndrome than men*.
*Source : http://www.orpha.net/consor/cgi-bin/index.php



HRA Pharma at your service with LYSOSAFE® Service

 

The HRA Pharma LYSOSAFE® Service is free of charge to all patients. The aim is to provide assistance with the use of Lysodren® – a medicine used in the treatment of Cushing’s syndrome – and to optimize the safety and efficacy of treatment.

closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?